Publications by authors named "T E Jacobson"

Article Synopsis
  • Statins are the primary medication for lowering bad cholesterol (LDL), but some patients experience muscle-related side effects known as statin-associated muscle symptoms (SAMS).
  • Recent guidelines from organizations like the National Lipid Association provide strategies for doctors to identify and manage patients with SAMS, as this is the most common reason for statin intolerance.
  • Many patients can still tolerate some statin therapy, and when combined with non-statin medications, an effective treatment plan can be created through open discussions between clinicians and patients to lower the risk of heart disease.
View Article and Find Full Text PDF

Nonrelativistic axions can be efficiently produced in the polar caps of pulsars, resulting in the formation of a dense cloud of gravitationally bound axions. Here, we investigate the interplay between such an axion cloud and the electrodynamics in the pulsar magnetosphere, focusing specifically on the dynamics in the polar caps, where the impact of the axion cloud is expected to be most pronounced. For sufficiently light axions m_{a}≲10^{-7}  eV, we show that the axion cloud can occasionally screen the local electric field responsible for particle acceleration and pair production, inducing a periodic nulling of the pulsar's intrinsic radio emission.

View Article and Find Full Text PDF

Plant cells sequester atmospheric carbon in thick walls containing heterogenous networks of cellulose and hemicelluloses (e.g. xylan and mannan), surrounded by additional polymers.

View Article and Find Full Text PDF

This National Lipid Association (NLA) Expert Clinical Consensus provides an overview of the physiologic and clinical considerations regarding the role of apolipoprotein B (apoB) measurement to guide clinical care based on the available scientific evidence and expert opinion. ApoB represents the total concentration of atherogenic lipoprotein particles in the circulation and more accurately reflects the atherogenic burden of lipoproteins when compared to low-density lipoprotein cholesterol (LDL-C). ApoB is a validated clinical measurement that augments the information found in a standard lipoprotein lipid panel; therefore, there is clinical value in using apoB in conjunction with a standard lipoprotein lipid profile when assessing risk and managing lipid-lowering therapy (LLT).

View Article and Find Full Text PDF